Can Mounjaro Cause Cold Feet — and Should You Be Concerned?

Cold feet are not listed as a recognised side effect in the Mounjaro Summary of Product Characteristics; reports are mainly from patients experiencing the broader 'feeling cold' effect linked to calorie deficit and weight change.
Rapid weight loss reduces metabolic heat production and shrinks the insulating fat layer under the skin, both of which can lower your baseline body temperature and make extremities feel colder.
Circulation changes, including reduced peripheral blood flow to the hands and feet, are a well-documented consequence of significant weight loss in general, not a specific tirzepatide effect.
Persistent, painful or one-sided coldness, numbness or colour change in the feet warrants prompt medical assessment to rule out unrelated vascular or neurological causes.

Cold feet and a general feeling of being colder than usual have been reported by some people using Mounjaro (tirzepatide), though neither appears in the medicine's core list of common side effects. The current evidence suggests any cold sensation is most likely a downstream effect of rapid weight loss and reduced calorie intake rather than a direct action of the medicine on circulation. Mounjaro is a prescription-only medicine; a GPhC-registered prescriber reviews your full health picture before it is dispensed. If your feet feel persistently cold, unusually numb, or noticeably pale, that is worth discussing with your clinical team rather than managing alone.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

What we know about cold extremities on Mounjaro, and when to act

What the clinical programme actually found — and what it stayed silent on

The SURMOUNT trials, which enrolled thousands of adults and produced the evidence base behind Mounjaro's UK licence, reported a well-characterised side-effect profile dominated by gastrointestinal symptoms: nausea, diarrhoea, constipation and indigestion top the list, as the NHS tirzepatide medicines page sets out in detail. Cold feet do not appear in that profile, and that absence is not the same as saying it cannot happen; it means the trials did not find it occurring more often in the tirzepatide group than in people taking a placebo.

What the trials did confirm, unambiguously, is significant weight loss. In SURMOUNT-1, participants on the 15mg dose lost around 20–21% of their body weight on average over 72 weeks. That scale of change carries its own physiological consequences, and feeling colder is one of them. The cold sensation many people notice on Mounjaro almost certainly belongs in that category rather than in a separate, medicine-specific bucket.

This distinction matters practically. It shapes whether the right response is adjusting treatment or simply layering up and eating enough protein. You can read a fuller look at the cold-on-treatment experience on our cold on Mounjaro page.

Why weight loss itself makes feet feel colder

Fat is not inert. It stores energy, yes, but it also acts as insulation and contributes to the metabolic rate that generates body heat. When body weight drops quickly, two things happen at once: resting metabolism slows slightly as the body adjusts to its new size, and the subcutaneous fat layer that buffers the skin from cold thins out. The result is that extremities, which have the highest surface-area-to-volume ratio in the body, lose heat faster than before.

There is also a circulatory element. Blood flow to the hands and feet is the first thing the body throttles when it prioritises warmth for core organs. In someone losing weight rapidly, peripheral circulation can be more variable than usual. None of this is dangerous in itself; it is the body doing exactly what bodies do during an energy deficit. The practical fix is often simple: eat regular warm meals, stay well hydrated, keep moving, and wear an extra pair of socks.

A common misconception worth gently addressing: some people worry that cold feet signal that Mounjaro is affecting the nerves or blood vessels of the legs directly. There is currently no clinical evidence to support that. The broader picture of foot-related symptoms on Mounjaro is worth reading if this is on your mind.

When cold feet deserve more than a warm pair of socks

Most cases of cold feet on Mounjaro will settle once the body has adapted to a new, lower weight and calorie level. But some presentations call for proper medical assessment, and it is important to be clear about them.

Seek prompt advice from your GP or a clinician if the coldness is one-sided, if it comes with pain, pallor or a bluish tinge, if one foot feels noticeably colder than the other, or if you also have numbness or tingling that does not resolve. These features can point to peripheral arterial disease, Raynaud's phenomenon, or a neurological issue, none of which are caused by Mounjaro but all of which can be aggravated or masked by treatment-related changes.

If you have questions specific to your situation, our clinical support team is available seven days a week. And for anything that feels urgent, your GP or 111 is the right first call. The MHRA's Yellow Card scheme also allows patients to report any suspected side effect, which helps build the evidence base for all GLP-1 medicines over time.

People sometimes ask whether this cold feeling might indicate something neurological, such as nerve involvement. That question comes up enough that we have a page looking at whether Mounjaro has any connection to neurological symptoms, the short answer, based on current evidence, is reassuring, but the full picture is there if you want it.

For a broader overview of how tirzepatide works and what to expect, the tirzepatide overview pulls together the mechanism, the trial evidence and the eligibility criteria in one place. If you are weighing up whether to start treatment, our prescribers can also clarify whether starting Mounjaro requires you to notify your GP, and the free consultation with our prescribers is the right place to bring all of these questions together, a real clinician reviews every case the same day.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions